 | Articles: Drug Trials |
Data from Pivotal Phase III Studies of Gilead's Letairis(R) (ambrisentan) for Pulmonary Arterial Hypertension (WHO Group 1) in Patients with WHO Functional Class II or III Symptoms Published in Circulation
Corporate News Releases, 06/02/08
Drug-Eluting Coronary Stents Utilizing Isotechnika's Lead Drug Receive Approval to Enter Clinical Trials
Corporate News Releases, 06/02/08
Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders
Corporate News Releases, 06/02/08
Merck Wins Appeal of First VIOXX(R) Case to go to Trial
Corporate News Releases, 06/02/08
Denosumab Achieved Superior Bone Mineral Density Gains in Head-to-Head Trial versus Weekly Alendronate (FOSAMAX(R))
Corporate News Releases, 05/30/08
EXTAVIA approved in European Union for treatment of multiple sclerosis, first in planned portfolio of therapies from Novartis
PharmiWeb, 05/30/08
Phase III Clinical Study Using BSD Medical's Systems for Treating Pancreatic Cancer to Be Announced at ASCO
Corporate News Releases, 05/30/08
A Placebo-Controlled Trial of Bupropion Combined with Nicotine Patch for Smoking Cessation in Schizophrenia
Biological Psychiatry, 05/29/08
Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials
BMC Psychiatry, 05/29/08
Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkin's Lymphoma
Corporate News Releases, 05/29/08
|
 Receive daily email updates on Drug Trials
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
|
